… Ocular hypertension secondary to … induced ocular hypertension (SIOH) has been linked to
a range of drug delivery routes including oral or intravenous, inhaled or intranasal, topical eye …

… corticosteroids (ICSs) combined with long-acting bronchodilators are indicated for patients
with COPD … Finally, we could not find clear evidence of increased risk of sepsis, eye disorders, …

… mitigation and, therefore, it is important to consider the risk of … those for inhaled anti-inflammatory
or bronchodilator drugs. … to infections, and ocular and oropharyngeal side effects. Many …

… The analysis of risk of bias carried out via the visual inspection of funnel plot evidenced
neither dispersion nor asymmetry ( Figure 3A, C, E, G ), as confirmed by the lack of statistical …

… , with onset of ocular and respiratory tract … , inhaled bronchodilators such as β-2-agonists
may assist those with bronchospasm and/or obstructive changes on lung function tests. Inhaled …

… salmeterol (an inhaled long-acting bronchodilator [LABA]) at 50 mg … of systemic corticosteroids
and ocular cataracts had been known … Inhaled steroids and risk of pneumonia for chronic …

… failure, prevention of extubation failure in high-risk patients, and acute hypercapnic COPD as
an … , thoracoabdominal aortic aneurysm, history of eye surgery or acute coronary syndrome …

… - and post- bronchodilation (nebulized albuterol 2.5 mg and … mometasone 200 mcg daily,
ocular ketotifen fumarate 0.025% … The study concluded that age by itself was not a risk factor for …

… The visual-only emphysema group had a significantly higher risk for mortality (… They also
responded less to inhaled bronchodilators (P < .01). Subjects with PSE had better lung function, …

… to take deep breaths using a visual target on the device in order to … There is a theoretic but
unsubstantiated risk that inhaled … Inhaled bronchodilators are useful in invasively ventilated …